September 25, 2014 - United States Government Policy for Institutional Oversight of Life Sciences DURC
On September 24 the United States Government issued the final US Policy for Institutional Oversight of Life Sciences Dual Use Research of Concern (DURC. The Office of Public Affairs sent a notice to members about the Oversight document.
September 23, 2014 - ASM Letter to the US HHS Concerning Scientific Resources in Response to the Ebola Virus Outbreak
The ASM sent a letter to Sylvia M. Burwell, Secretary US Department of Health & Human Services with recommendations concerning scientific resources that are needed in response to the Ebola virus outbreak.
September 23, 2014 - ASM Letter to the UN Concerning Scientific Resources in Response to the Ebola Virus Outbreak
The ASM sent a letter to David Nabarro, M.D., Senior United Nations System Coordinator for Ebola Virus Disease with recommendations concerning scientific resources that are needed in response to the Ebola virus outbreak.
The ASM sent a statement on the National Strategy to Combat Antibiotic Resistant Bacteria, which was announced by President Obama on September 18, 2014 to ASM members, Congress and representatives of various federal agencies.
The ASM sent a statement to members of Congress regarding the response to the Ebola outbreak in Western Africa encouraging additional support for research and public health programs.
NIGMS seeks comments on their draft strategic plan. ASM requests member comments to help formulate the Society's response.
The ASM sent an e-mail to ASM members regarding US Government communications about ensuring biosafety in US laboratories. The e-mail includes links to a White House memo and an NIH advisory.
The National Institutes of Health (NIH) announces National Biosafety Stewardship Month
ASM sent a statement out to ASM members reminding them to practice safe "laboratory housekeeping."
ASM commented on an FDA proposal to reclassify antigen based rapid influenza virus antigen detection test systems intended to detect influenza virus directly from clinical specimens.